ANDREW BIERMAN: Open Payments
NPI 1306408505 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,484 in 22 payments from 7 companies in 2025. Trend: 2023 $1,596 · 2024 $564 · 2025 $5,484
Consulting: $4,200Food & beverage: $672Travel & lodging: $612
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 7 | $4,378 |
| TG Therapeutics, Inc. | 3 | $561 |
| Alexion Pharmaceuticals, Inc. | 1 | $250 |
| Amgen Inc. | 4 | $114 |
| Novartis Pharmaceuticals Corporation | 4 | $107 |
| GENZYME CORPORATION | 2 | $42 |
| Celgene Corporation | 1 | $32 |
Products named: Ocrevus, BRIUMVI, ULTOMIRIS, UPLIZNA, KESIMPTA, ZEPOSIA, Ocrevus Zunovo.
Industry payments across CA — which companies pay providers there.
